This Father’s Day, We Applaud Horse Show Dads

Most every equestrian can agree – they wouldn’t be where they are today without the encouragement from key people in their lives. This Father’s Day, it’s time to #ShowDadLove, honoring the men who support equestrians through all of their accomplishments.

Last year, Merial, now part of Boehringer Ingelheim, prompted equestrians to #ShowDadLove throughout the month of June, and we received a great response. We loved seeing the enthusiasm around thanking Show Dads. On the heels of last year’s campaign, we are encouraging equestrians to join us again, showcasing their appreciation for the love and support given by the men who are part of their horse show families.

Join the fun on our Facebook page, The Ride to Win, by creating a new Facebook profile photo with a special Show Dad Love overlay to use around Father’s Day. Use the hashtag #ShowDadLove with your photo to honor the Show Dad in your life.

“Show Dads take a special place in the heart of equestrians,” says Kristopher Scott, Director of Equine Marketing for Boehringer Ingelheim Animal Health. “We can’t wait to see everyone’s #ShowDadLove photos all over social media.”

Show Dad Love is brought to you by Boehringer Ingelheim, the largest equine health company worldwide.

Remember to #ShowDadLove on Facebook and Instagram in June, and visit our Facebook page, The Ride to Win. We are excited to see how much love equestrians have for their Show Dads.

As the second largest animal health business in the world, Boehringer Ingelheim is committed to improving animal health. With more than 10,000 employees worldwide, Boehringer Ingelheim Animal Health has products available in more than 150 markets and a global presence in 99 countries. For more information about Boehringer Ingelheim Animal Health, click here.

Boehringer Ingelheim

Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the industry’s top 20 pharmaceutical companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.